Last update 23 Jan 2025

SSGJ-706

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Target
PD-1 x PDL1
Mechanism
PD-1 inhibitors(Programmed cell death protein 1 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication
Lymphoma
Originator Organization
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Active Organization
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SSGJ-706
CTR20242754
/ RecruitingPhase 1
评价 SSGJ-706 单药在晚期实体瘤患者中的安全性、耐受性和初步疗效的 I 期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability and preliminary efficacy of SSGJ-706 monotherapy in patients with advanced solid tumors
NCT06533605
/ Not yet recruitingPhase 1
Phase I Clinical Study to Evaluate the Safety, Tolerability, and Initial Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors
100 Clinical Results associated with SSGJ-706
Login to view more data
100 Translational Medicine associated with SSGJ-706
Login to view more data
100 Patents (Medical) associated with SSGJ-706
Login to view more data
100 Deals associated with SSGJ-706
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LymphomaPhase 3
CN
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
27 Dec 2021
NeoplasmsPhase 3
US
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
14 Oct 2021
Advanced Malignant Solid NeoplasmPhase 1-
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
01 Aug 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free